Please wait
0000748592 EX-FILING FEES S-1/A Common Stock, issuable to Placement Agent as Agents Shares Common Stock, issuable to Placement Agent as Agents Shares Common Stock, issuable to Placement Agent as Agents Shares 0000748592 2026-02-05 2026-02-05 0000748592 1 2026-02-05 2026-02-05 0000748592 2 2026-02-05 2026-02-05 0000748592 3 2026-02-05 2026-02-05 0000748592 4 2026-02-05 2026-02-05 0000748592 5 2026-02-05 2026-02-05 0000748592 6 2026-02-05 2026-02-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

EXHIBIT 107

 

Calculation of Filing Fee Table

 

Form S-1

(Form Type)

 

Ernexa Therapeutics Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

  

Security

Type

 

Security

Class Title

 

Fee

Calculation Rule

 

Amount to be

Registered

  

Proposed

Maximum

Offering

Price Per

Unit

  

Proposed

Maximum

Aggregate

Offering

Price

   Fee Rate  

Amount of

Registration

Fee

 
Fees to Be Paid  Equity  Common Stock, par value $0.005 per share  Rule 457(o)        $           $12,500,000    0.0001381   $1,726.25 
   Equity  Common Stock, issuable to Placement Agent as Agent’s Shares  Rule 457(o)       $    $187,500    0.0001381   $25.89 
   Equity 

Pre-Funded Warrants to purchase Common Stock

 

Rule 457(o) (1)

        

-

    

-

    

-

    

-

 
   Equity 

Common Stock issuable upon exercise of the Pre-Funded Warrants

 

Rule 457(i) (1)

   -    

-

    

-

    

-

    

-

 
   Equity  Common Warrants to purchase Common Stock  Other (2)       -    -    0.0001381-    - 
   Equity  Common stock issuable upon exercise of the Common Warrants  Rule 457(o)       $    $12,500,000    0.0001381   $1,726.25 
Total Offering Amounts  $25,187,500        $3,478.39 
Total Fees Previously Paid            $5,565.43 
Total Fee Offsets            $- 
Net Fee Due            $- 

 

(1) The proposed maximum aggregate offering price of the Common Stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the Pre-Funded Warrants offered and sold in the offering (plus the aggregate exercise price of the Common Stock issuable upon exercise of the Pre-Funded Warrants).
   

(2)

In accordance with Rule 457(g) under the Securities Act, because the Common Stock of the registrant underlying the Common Warrants are registered hereby, no separate registration fee is required with respect to the Common Warrants registered hereby.

N/A